Sr. VP and President at Medtronic, USA
Sr. VP and President at Medtronic, USA
Nina Goodheart is the Vice President and General Manager Medtronic Renal Denervation (RDN).
As Vice President and General Manager for Medtronic Renal Denervation Nina has global market responsibility for the Medtronic renal denervation franchise.
Previous to th is role Nina served as Vice President of Marketing for Medtronic CRDM, where she had global responsibility for product marketing, market development, healthcare economics, patient management, sales training and medical education.
Nina joined Medtronic as Vice President of CRDM Market Development in 2007, after 20+ years providing strategic consulting to pharmaceutical and medical device companies.
Prior to Medtronic, Nina was at Sullivan & Co, a strategic consulting agency in New York, where she worked on market development initiatives for Johnson and Johnson, as well as on Medtronic Vascular’s drug eluting stent launches.
Prior to that, Nina was Managing Director for Euro RSCG Life, a global strategic healthcare agency in New York and New Jersey where she was responsible for US and global market
development and strategic marketing for products such as Lovenox, Plavix and Tysabri (for MS).
In addition, she has worked with Cordis, Genzyme, Sanofi-Aventis, BMS, Merck and AstraZeneca on their cardiology and metabolic franchises.
Nina earned her bachelor’s from Northwestern University and her MBA from New York University.